What Make Xarelto Lawsuit Don t Want You To Know
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, which includes the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to complete so might be grounds for compensation. Our lawyers are operating difficult to have these hurt by the drug the compensation they're entitled to.
Whilst bleeding is a widespread complication connected with anticoagulants, it has been alleged that Xarelto is a lot more harmful than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, individuals may possibly be at danger for irreversible bleeding issues, such as life-threatening internal and gastrointestinal hemorrhaging.
In case you or even a loved 1 suffered a serious bleeding event soon after taking Xarelto, you may have legal recourse. For far more info, contact us these days to possess your case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in situations of death, funeral expenditures. In addition, they're searching for punitive damages, that are usually awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood clot xarelto loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.
Visit this page for much more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.